RAC1 and infection: The use of dominant negative Rac1 and PAK1 mutants reduced macropinocytosis and infection, in contrast to the outcomes achieved with a dominant positive Rac1 mutant, which stimulated the A-MLV infection of mouse embryo fibroblast cells [68].